Company · CIK 1835268

# Connect Biopharma Holdings Ltd

| CIK | [1835268](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001835268) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | CA |
| Listed | CNTB (Nasdaq) |
| First annual or quarterly report | 2022-03-31 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-295921 | Shelf Effective | 2026-05-15 | 2026-06-01 | 2 |
| 333-287918 | Shelf Effective | 2025-06-10 | 2025-09-12 | 3 |
| 333-264340 | Shelf Effective | 2022-04-15 | 2022-07-06 | 2 |
| 333-253631 | IPO Final prospectus | 2021-02-26 | 2021-03-19 | 6 |

## Filings

 15

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-06-01 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1835268/999999999526001825/9999999995-26-001825-index.htm) Declared effective | 333-295921 | 9999999995-26-001825 |
| 2026-05-15 | [F-3](https://www.sec.gov/Archives/edgar/data/1835268/000119312526225436/0001193125-26-225436-index.htm) Shelf registered | 333-295921 | 0001193125-26-225436 |
| 2025-09-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1835268/999999999525002945/9999999995-25-002945-index.htm) Declared effective | 333-287918 | 9999999995-25-002945 |
| 2025-06-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1835268/999999999525002040/9999999995-25-002040-index.htm) Declared effective | 333-287918 | 9999999995-25-002040 |
| 2025-06-10 | [F-3](https://www.sec.gov/Archives/edgar/data/1835268/000119312525138482/0001193125-25-138482-index.htm) Shelf registered | 333-287918 | 0001193125-25-138482 |
| 2022-07-06 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1835268/999999999522001972/9999999995-22-001972-index.htm) Declared effective | 333-264340 | 9999999995-22-001972 |
| 2022-04-15 | [F-3](https://www.sec.gov/Archives/edgar/data/1835268/000119312522106928/0001193125-22-106928-index.htm) Shelf registered | 333-264340 | 0001193125-22-106928 |
| 2021-03-19 | [424B4](https://www.sec.gov/Archives/edgar/data/1835268/000119312521087643/0001193125-21-087643-index.htm) Final prospectus | 333-253631 | 0001193125-21-087643 |
| 2021-03-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1835268/999999999521001011/9999999995-21-001011-index.htm) Declared effective | 333-254215 | 9999999995-21-001011 |
| 2021-03-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1835268/999999999521001006/9999999995-21-001006-index.htm) Declared effective | 333-253631 | 9999999995-21-001006 |
| 2021-03-18 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1835268/000119312521084781/0001193125-21-084781-index.htm) Amendment | 333-253631 | 0001193125-21-084781 |
| 2021-03-17 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1835268/000119312521083442/0001193125-21-083442-index.htm) Amendment | 333-253631 | 0001193125-21-083442 |
| 2021-03-12 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1835268/000119312521079813/0001193125-21-079813-index.htm) Amendment | 333-253631 | 0001193125-21-079813 |
| 2021-02-26 | [F-1](https://www.sec.gov/Archives/edgar/data/1835268/000119312521060795/0001193125-21-060795-index.htm) Registration filed | 333-253631 | 0001193125-21-060795 |
| 2020-12-17 | [DRS](https://www.sec.gov/Archives/edgar/data/1835268/000095012320012706/0000950123-20-012706-index.htm) Draft made public | 377-03905 | 0000950123-20-012706 |

[All filings of this company](https://equitycapital.markets/filings?cik=1835268) · [CSV](https://equitycapital.markets/filings.csv?cik=1835268)

---
Source page: https://equitycapital.markets/company/1835268 · Data: U.S. SEC EDGAR · CC BY 4.0